Amicus TherapeuticsFOLD
13F holders, Q2 2026 (June 30)2holders −296
0new positions
292sold out
$14.49avg. 13F price*
At the end of Q2 2026, 2 institutions reported holding Amicus Therapeutics Inc. (FOLD) in their 13F filings, down 296 from Q1 2026. 0 opened new positions and 292 sold out. The largest holders were IFP Advisors, Inc ($12K) and Huntington National Bank ($14).
- Company
- Amicus Therapeutics Inc.
- CUSIP
- 03152W109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 292 | $4.8B |
All 13F filers, Q1 2026 → Q2 2026: 329,741,049 shares sold, net −329,741,049 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| IFP Advisors, Inc | 0.00% | Reduce -2.2% | 796 | $12K |
| Huntington National Bank | 0.00% | No change | 1 | $14 |
"% of holder's portfolio" is FOLD's weight in each manager's 13F, not the share of Amicus Therapeutics Inc. the manager owns.